Whistleblower Takes Takeda FCA Case To Supreme Court
A Takeda Pharmaceuticals North America Inc. sales leader has asked the U.S. Supreme Court to revive his whistleblower suit accusing the company of defrauding Medicare by overbilling for stomach acid drug...To view the full article, register now.
Already a subscriber? Click here to view full article